BIOMATERIALS
Scope & Guideline
Transforming Ideas into Advanced Biomaterials Solutions
Introduction
Aims and Scopes
- Biomaterials for Regenerative Medicine:
Research in this area focuses on the development and application of biomaterials that can support tissue regeneration and repair, including scaffolds, hydrogels, and 3D printed constructs designed to enhance healing in various tissues. - Nanomedicine and Drug Delivery Systems:
This scope encompasses the design and application of nanomaterials for targeted and controlled drug delivery, enhancing therapeutic efficacy while minimizing side effects, particularly in cancer treatment and chronic diseases. - Bioengineering and Tissue Engineering:
The journal highlights studies that integrate engineering principles with biological systems, focusing on the creation of functional tissues and organs, including organ-on-a-chip technologies and bioprinting. - Immunomodulation and Therapeutic Applications:
Research that explores how biomaterials can modulate immune responses to improve therapeutic outcomes, particularly in cancer immunotherapy and regenerative medicine. - Biocompatibility and Safety Evaluation:
The journal publishes studies assessing the biocompatibility, toxicity, and long-term effects of biomaterials in biological systems, which are critical for their clinical translation. - Smart Biomaterials and Responsive Systems:
This area includes the development of materials that respond to environmental stimuli (e.g., pH, temperature, light) for dynamic therapeutic applications.
Trending and Emerging
- Advanced Nanotherapeutics:
There is a growing emphasis on the development of nanomaterials that can deliver drugs or therapeutic agents with high precision, including nanocarriers that enhance the efficacy of immunotherapies and chemotherapies. - 3D Bioprinting and Organ-on-a-Chip Technologies:
The trend towards creating complex tissue structures using 3D bioprinting techniques is increasing, along with the development of organ-on-a-chip systems that mimic human organ functions for drug testing and disease modeling. - Biomaterials for Cancer Immunotherapy:
Research is trending towards the use of biomaterials as platforms for cancer immunotherapy, focusing on how these materials can enhance immune responses and target tumor microenvironments. - Smart and Responsive Biomaterials:
There is an emerging interest in biomaterials that respond to specific stimuli (light, temperature, pH), allowing for on-demand drug release and dynamic therapeutic applications. - Microenvironment Engineering:
An increasing number of studies are focusing on how the engineered microenvironment can influence cell behavior, particularly in the context of stem cell therapy and tissue regeneration. - Sustainable and Green Biomaterials:
There is a rising trend towards developing environmentally friendly biomaterials derived from natural sources, emphasizing sustainability and biocompatibility.
Declining or Waning
- Traditional Biomaterials without Functionalization:
There has been a noticeable decrease in studies focusing solely on traditional biomaterials (such as simple hydrogels or polymers) without advanced functionalization or modification to enhance their properties or applications. - In vitro Studies without Translation to In Vivo Models:
Research that remains solely within in vitro studies without progressing to in vivo validation is declining, as there is a greater emphasis on translational research that can lead to practical applications in clinical settings. - Non-targeted Drug Delivery Approaches:
As precision medicine becomes more prominent, there is a waning interest in non-targeted drug delivery systems, with more focus shifting towards targeted and personalized therapies. - Static Biomaterial Studies:
Static studies that do not incorporate dynamic or responsive elements in biomaterials are becoming less frequent, as there is a growing interest in materials that can adapt to physiological conditions.
Similar Journals
International Journal of Nanomedicine
Exploring the frontiers of nanotechnology in medicine.International Journal of Nanomedicine, published by DOVE MEDICAL PRESS LTD, is a leading open access journal dedicated to advancing the field of nanomedicine and its applications in healthcare. Since its establishment in 2006, the journal has grown significantly, now encompassing a wide array of topics including bioengineering, biomaterials, biophysics, drug discovery, and pharmaceutical sciences, and is recognized in Q1 quartiles across major categories like *Nanoscience and Nanotechnology* and *Organic Chemistry*. The journal boasts an impressive standing within the Scopus rankings, with high percentiles across various related fields, making it an invaluable resource for researchers, professionals, and students seeking to stay informed on the latest innovations and developments in nanomedicine. With its commitment to fostering an accessible and collaborative academic environment, the International Journal of Nanomedicine serves as a vital platform for disseminating transformative research that impacts scientific practice and healthcare outcomes globally.
Bioactive Materials
Catalyzing Discoveries in Bioactive Materials and ApplicationsBioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.
Materials Science & Engineering C-Materials for Biological Applications
Innovating the intersection of materials science and biology.Materials Science & Engineering C-Materials for Biological Applications is a premier journal published by ELSEVIER, dedicated to advancing the field of biomaterials through interdisciplinary research. With a robust ISSN of 0928-4931, this journal has made its mark in the realms of Chemical Engineering and Materials Science, achieving impressive Scopus rankings within its categories, namely Rank #16/151 in Bioengineering (89th percentile) and Rank #13/112 in Biomaterials (88th percentile). Although the journal's coverage in Scopus has been discontinued since 2021, it remains a critical resource for researchers, professionals, and students eager to explore innovative materials and their applications in biological contexts. The journal’s open access policy enhances its accessibility, fostering a global exchange of knowledge and inspiring future advancements in the field of materials science.
Journal of Tissue Engineering and Regenerative Medicine
Bridging engineering and medicine for transformative health.Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.
Biomedical Materials
Bridging Biology and Engineering for Medical Breakthroughs.Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.
MACROMOLECULAR BIOSCIENCE
Catalyzing Innovation in the World of MacromoleculesMACROMOLECULAR BIOSCIENCE, published by WILEY-V C H VERLAG GMBH, is a leading journal in the fields of bioengineering, biomaterials, biotechnology, materials chemistry, and polymers and plastics. With a convergence of scientific inquiry since its inception in 2001, the journal has established itself as a vital resource for researchers and professionals exploring the interface of molecular sciences and biosystems. It boasts impressive Scopus rankings, including Q1 status in multiple categories, reflecting its significant contribution to advancing knowledge and innovation in the polymer and biomaterials domains. While the journal does not currently offer open access options, its rigorous peer-review process ensures the publication of high-quality research that fuels academic discourse. Positioned in Weinheim, Germany, MACROMOLECULAR BIOSCIENCE aims to bridge theoretical understanding with practical applications, making it an essential reference for students, academics, and industry practitioners dedicated to the evolving landscape of macromolecular bioscience.
APL Bioengineering
Advancing Bioengineering for a Healthier TomorrowAPL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.
Biomaterials Advances
Connecting Researchers to the Cutting Edge of BiomaterialsBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.
Biomaterials Research
Transforming research into real-world applications.Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.
Advanced NanoBiomed Research
Pioneering Research in NanobiomedicineAdvanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.